TAMPA, FL – A cancer treatment technology developed at the University of South Florida (USF) is entering veterinary trials, offering potential hope for pet owners facing difficult diagnoses. The device, born from decades of federally funded research at USF, utilizes a targeted approach to deliver cancer treatment, minimizing harm to healthy tissue.

The innovative technology employs a combination of gentle heat and precisely calibrated electrical pulses. This method allows for the direct delivery of treatment specifically to tumors, rather than relying on systemic therapies like chemotherapy that can affect the entire body. Researchers say this targeted approach could significantly reduce side effects and improve the quality of life for animals undergoing treatment.

The research behind this device began years ago with initial funding from federal grants focused on exploring novel cancer treatment methods. Scientists at USF have been steadily refining the technology, demonstrating promising results in preclinical studies. The current veterinary trials represent a crucial step towards potential broader application.

While the specifics of the trials, including the types of cancers being targeted and the number of animals involved, were not detailed in the initial announcement, the commencement of these trials signals a significant milestone for the USF-developed technology. If successful, this approach could revolutionize cancer treatment for pets, providing a safer and more effective alternative to existing methods. Further updates on the trial's progress are expected as data becomes available.